Here are some additional articles published by cannabis clinicians in O’Shaughnessy’s showing the strength of aggregated case reports. We hope the MBC Marijuana Task Force will give them serious consideration.

Marijuana in California, 1996-2006 by Mikuriya et al

Cannabis Eases Post Traumatic Stress by Tod Mikuriya, MD

Cannabis as a First-line Treatment for Childhood Mental Disorders by Tod Mikuriya MD

Cannabis Alleviates Symptoms of Crohn’s Disease by Jeffrey Hergenrather, MD

About My Practice by Jeffrey Hergenrather, MD

SCC Study of Crohn’s Patients: A Template for clinical research? by Jeffrey Hergenrather, MD  (after  Abrams and Sidney)

On the subject of cannabis clinicians’ practice standards:

Implementation of the Compassionate Use Act in a Family Medical Practice by Frank Lucido and M. Mangini

The MBC should recognize that the disparaging term “potdoc” applies to a wide spectrum of practitioners, from quick-buck artists to serious specialists who keep abreast of the literature, attend cannabinoid research symposia, and share their findings and observations with colleagues and patients.

The Enforcement Division does not have a simple task. One thought that occurred to me —if the proposed algorithms are adopted as a way to trigger investigations— is that physicians who issue more than a given number of cannabis approvals should be required to take a CME course. The Society of Cannabis Clinicians has produced one, but with 13 modules it might be a bit much to ask of those seeking to acquire a basic introduction to the field of Cannabis-Based Medicine. I trust they could develop a one- or two-hour California-centric educational program.

It might also be useful to have a clinician with indisputably high practice standards make a presentation to the Enforcement Division. SCC President Jeffrey Hergenrather, MD, would be well-received, I think.

Fred Gardner